J

Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015

Watchlist Manager
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Watchlist
Price: 156 SAR 4.7% Market Closed
Market Cap: 10.9B SAR
Have any thoughts about
Jamjoom Pharmaceuticals Factory Company SJSC?
Write Note

Income Statement

Earnings Waterfall
Jamjoom Pharmaceuticals Factory Company SJSC

Revenue
1.2B SAR
Cost of Revenue
-458m SAR
Gross Profit
773.7m SAR
Operating Expenses
-415.9m SAR
Operating Income
357.8m SAR
Other Expenses
-26.1m SAR
Net Income
331.7m SAR

Income Statement
Jamjoom Pharmaceuticals Factory Company SJSC

Rotate your device to view
Income Statement
Currency: SAR
Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
1 517
N/A
1 810
+19%
1 101
-39%
1 184
+8%
1 232
+4%
Gross Profit
Cost of Revenue
(525)
(631)
(397)
(431)
(458)
Gross Profit
992
N/A
1 179
+19%
704
-40%
754
+7%
774
+3%
Operating Income
Operating Expenses
(572)
(674)
(392)
(408)
(416)
Selling, General & Administrative
(522)
(616)
(353)
(376)
(384)
Research & Development
(50)
(59)
(24)
(32)
(32)
Depreciation & Amortization
0
0
(8)
0
0
Other Operating Expenses
0
0
(7)
0
0
Operating Income
420
N/A
504
+20%
312
-38%
346
+11%
358
+3%
Pre-Tax Income
Interest Income Expense
(50)
(51)
3
(9)
(4)
Non-Reccuring Items
0
0
(1)
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
Total Other Income
1
2
2
(0)
0
Pre-Tax Income
371
N/A
455
+23%
316
-31%
337
+7%
354
+5%
Net Income
Tax Provision
(29)
(36)
(23)
(26)
(22)
Income from Continuing Operations
342
419
292
311
332
Net Income (Common)
342
N/A
419
+23%
292
-30%
311
+6%
332
+7%
EPS (Diluted)
4.89
N/A
5.99
+22%
4.18
-30%
4.44
+6%
4.74
+7%

See Also

Discover More